1. Home
  2. CCEL vs NEPH Comparison

CCEL vs NEPH Comparison

Compare CCEL & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

SELL

Current Price

$4.42

Market Cap

32.7M

Sector

Health Care

ML Signal

SELL

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$3.65

Market Cap

39.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCEL
NEPH
Founded
1989
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Managed Health Care
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.7M
39.0M
IPO Year
2022
2004

Fundamental Metrics

Financial Performance
Metric
CCEL
NEPH
Price
$4.42
$3.65
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $6.25
AVG Volume (30 Days)
10.5K
★ 35.2K
Earning Date
10-09-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 1000.00
EPS
★ 0.23
0.12
Revenue
★ $25,384,279.00
$18,789,000.00
Revenue This Year
N/A
$17.81
Revenue Next Year
N/A
$15.90
P/E Ratio
★ $15.87
$29.25
Revenue Growth
9.76
★ 32.67
52 Week Low
$2.72
$2.66
52 Week High
$4.90
$6.42

Technical Indicators

Market Signals
Indicator
CCEL
NEPH
Relative Strength Index (RSI) 51.91 42.92
Support Level $3.15 $2.86
Resistance Level $4.71 $3.78
Average True Range (ATR) 0.38 0.30
MACD -0.01 0.00
Stochastic Oscillator 53.06 43.65

Price Performance

Historical Comparison
CCEL
NEPH

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: